Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

genera inc - avian infectious bronchitis virus, live - lyophilisate for oculonasal suspension/use in drinking water - . - avian infectious bronchitis virus

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

genera inc - avian infectious bursal disease virus, live - lyophilisate for use in drinking water - . - avian infectious bursal disease virus (gumboro disease)

Ευρωπαϊκή Ένωση - Αγγλικά - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - chicken - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

Τανζανία - Αγγλικά - Tanzania Medicinces & Medical Devices Authority

genera inc., croatia - lentogenic newcastle disease virus, strain la sota , avian infectious bronchitis virus, strain h-120 - lyophilized cake - lentogenic newcastle disease virus, strain la sota ....106.0 tcid50 – 107.0 tcid50 avian infectious bronchitis virus, strain h-120…..103.5- 104.5 eid50

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - avian infectious bursal disease virus, live - effervescent tablet - . - avian infectious bursal disease virus (gumboro disease)

Ευρωπαϊκή Ένωση - Αγγλικά - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - chicken - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis. 

Φιλιππίνες - Αγγλικά - FDA (Food And Drug Administration)

msd animal health (phils.), inc. - inactivated infectious bronchitis (ib) virus , avian rhinotracheitis (art) virus , infectious bursal disease (ibd) virus , newcastle disease (nd) virus vaccine (vet.) - emulsion for injection ection (im/sc) - formulation: each 0.5 ml (dose) contains: infectious bronchitis (ibd) virus (massachusetts type, m41 strain) infectious bronchitis (d274/d207 type, 249g strain) avian rhinotracheitis (art) virus (buti #8544 strain) infectious bursal disease (ibd) virus (d78 strain) newcastle disease (nd) virus (lasota, clone 30 strain) hi - hemaglutination inhibition vn - virus neutralization pd - protective dose elisa-enzyme-linked immunosorbent assay > 4 log2 vn units > 4 log 2 vn units > 9.5 log, elisa units > 14.5 log2 vn units 250 pd50/4log, hi units per 1750

Φιλιππίνες - Αγγλικά - FDA (Food And Drug Administration)

msd animal health (phils.), inc. - inactivated infectious bronchitis (ib) virus , avian rhinotracheitis (art) virus , infectious bursal disease (ibd) virus , newcastle disease (nd) virus vaccine (vet.) - emulsion for injection ection (im/sc) - formulation: each 0.5 ml (dose) contains: infectious bronchitis (ibd) virus (massachusetts type, m41 strain) infectious bronchitis (d274/d207 type, 249g strain) avian rhinotracheitis (art) virus (buti #8544 strain) infectious bursal disease (ibd) virus (d78 strain) newcastle disease (nd) virus (lasota, clone 30 strain) hi - hemaglutination inhibition vn - virus neutralization pd - protective dose elisa-enzyme-linked immunosorbent assay > 4 log2 vn units > 4 log 2 vn units > 9.5 log, elisa units > 14.5 log2 vn units 250 pd50/4log, hi units per 1750

Φιλιππίνες - Αγγλικά - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - live newcastle disease (nd) virus , avian infectious bronchitis (ib) virus vaccine (vet.) - freeze-dried tablet for suspension (intraocular/intranasal/oral/aerosol) - formulation: each dose contains: newcastle disease virus (b1 strain)............> 10^6.5 eid50* avian infectious bronchitis virus (h120) > 10^3 eid50* *eid-embryo infotive dose

Φιλιππίνες - Αγγλικά - FDA (Food And Drug Administration)

ceva animal health (philippines), inc.; distributor: ceva animal health (philippines), inc. - inactivated newcastle disease (nd) virus , avian infectious bronchitis (ib) virus , egg drop syndrome (eds) virus , avibacterium paragallinarum , salmonella enteritidis vaccine (vet.) - emulsion for injection (im/sc) - each 0.5 ml (dose) contains: newcastle disease virus (ndv-sz lasota strain) iv 26log2 hi titre with 1 dose/ 4log2 hi titre with 1/50 dose/ >50pd50 > 4.4log2 hi titre >7log2 hi titre > 107 cfu > 107cfu > 10' cfu > 5log2 mat titre avian infectious bronchitis virus (m-41 strain) egg drop syndrome virus (b8/78 strain) avibacterium paragallinarum (serotype a, serovar 221) avibacterium paragallinarum (serotype b) avibacterium paragallinarum (serotype c, serovar modesto) salmonella enteritidis (038-090 strain) pd50-protective dose 50% in ndv challenge hi-hemagglutination inhibition cfu-colony forming unit before mactivation mat-micto-agglutination tesi v v iv